Last updated on June 2019

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)


Brief description of study

This research study will examine the safety and effectiveness of ONS-5010 in participants with AMD. The goal is to prevent vision loss by evaluating the effectiveness of ONS-5010 as compared with ranibizumab.

Clinical Study Identifier: NCT03844074

Find a site near you

Start Over

Clinical Site

Hurstville, Australia
  Connect »

Clinical Site

Liverpool, Australia
  Connect »

Clinical Site

Sydney, Australia
  Connect »

Clinical Site

Westmead, Australia
  Connect »

Clinical Site

Brisbane, Australia
  Connect »

Clinical Site

Adelaide, Australia
  Connect »

Clinical Site

Hobart, Australia
  Connect »

Clinical Site

Essendon, Australia
  Connect »

Clinical Site

Glen Waverley, Australia
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.